INVO Bioscience, Inc. (INVO) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by INVO Bioscience, Inc. on September 29, 2023. The report addresses a corporate governance event rather than a standard financial reporting period. The Company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC under the symbol "INVO."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a specific event and does not contain audited or unaudited financial statements.
Material Changes and Events
- Shareholder Meeting Adjournment: On September 29, 2023, the Company announced the adjournment of its special meeting of shareholders.
- Reference Material: The announcement is detailed in a press release dated September 29, 2023, which is included as Exhibit 99.1 and incorporated by reference.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, operational outlook, or specific risk factors beyond the implications of the adjourned shareholder meeting. No unusual items or contingencies are described in the text of this specific 8-K form.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to understand the reasons for the adjournment of the special shareholder meeting.
- Verify the new date and agenda for the rescheduled shareholder meeting, if announced.
- Check subsequent filings for any updates on the matters originally intended for the special meeting.